Profiel
Alex Mercer worked as the Director of Clinical Development at Calliditas Therapeutics AB and as the Head of Discovery at Newron Sweden AB from 2000 to 2010.
He holds a doctorate degree from University College London.
Eerdere bekende functies van Alex Mercer
| Bedrijven | Functie | Einde |
|---|---|---|
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | - |
Opleiding van Alex Mercer
| University College London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
